References
- Klepin, H. D., Estey, E., & Kadia, T. (2019): More versus less therapy for older adults with acute myeloid leukemia: new perspectives on an old debate. American Society of Clinical Oncology Educational Book, 39, 421–432.
- Jung, H.-W. (2021). Frailty as a clinically relevant measure of human aging. Annals of geriatric medicine and research, 25(3), 139.
- Gupta, G., & Garg, V. (2023): Management of Newly Diagnosed Acute Myeloid Leukemia in Older Adults. In Leukemia-From Biology to Clinic. IntechOpen.
- Borlenghi, E., Pagani, C., Zappasodi, P., Bernardi, M., Basilico, C., Cairoli, R., ... & Rossi, G. (2021): Validation of the “fitness criteria” for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL): Journal of Geriatric Oncology, 12(4), 550–556.
- Bellera, C., Rainfray, M., Mathoulin-Pélissier, S., Mertens, C., Delva, F., Fonck, M., & Soubeyran, P. (2012). Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Annals of Oncology, 23(8), 2166–2172.
- Soubeyran, P., Bellera, C., Gregoire, F., Blanc, J., Ceccaldi, J., Blanc-Bisson, C., . . . Rainfray, M. (2008). Validation of a screening test for elderly patients in oncology. Journal of Clinical Oncology, 26(15_suppl), 20568–20568.
- Bonanad, S., De la Rubia, J., Gironella, M., Persona, E.P., González, B., Lago, C.F., Arnan, M., Zudaire, M., Rivas, J.H., Soler, A. and Marrero, C., (2015): Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale. Journal of geriatric oncology, 6(5), pp.353–361.
- Hassan, S. K. (2015). A study of morbidity pattern among geriatric population in Fayoum Governorate, Egypt. Journal of American Science, 11(4), 90–95.
- Ahmed, M. N., M Hassan, N., & Morghany, E. (2023). Towards Elderly-Friendly Home Environments in Egypt: Exploring Elderly Challenges, Needs, and Adaptive Strategies to Promote Aging in Place. JES. Journal of Engineering Sciences, 51(4), 260–286.
- Bouzan, J., Nellas, S., Stoilkov, B., Willschrei, P., & Horstmann, M. (2023). Item analysis of G8 screening in uro-oncologic geriatric patients. International Urology and Nephrology, 1–6.
- Cruz-Jentoft AJ, Gonzalez B, de la Rubia J, Hernandez Rivas JA, Soler JA, Fernandez Lago C, et al. (2017): Further psychometric validation of the GAH scale: responsiveness and effect size. J Geriatr Oncol 2017
- Döhner H, Estey E, Grimwade D, et al. (2017): Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood, The Journal of the American Society of Hematology, 129:424–447.
- ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., . . . Isaacs, D. (2023). 2. Classification and diagnosis of diabetes: standards of care in diabetes—2023. Diabetes care, 46(Supplement_1), S19–S40.
- Flack, J. M., & Adekola, B. (2020). Blood pressure and the new ACC/AHA hypertension guidelines. Trends in cardiovascular medicine, 30(3), 160–164.
- Strickland, S. A., Shaver, A. C., Byrne, M., Daber, R. D., Ferrell, P. B., Head, D. R., . . . Stricker, T. P. (2018). Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia. Leukemia research, 65, 67–73.
- Sweed, H. S. (2016). Population ageing: Egypt report. Middle East Journal of Age and Ageing, 83(4013), 1–8.
- Atakul, E., & Akyar, İ. (2019): Frailty prevalence and characteristics in older adults with hematologic cancer: a descriptive study. Asia-Pacific Journal of Oncology Nursing, 6(1), 43–49.
- Vetrano, D. L., Palmer, K. M., Galluzzo, L., Giampaoli, S., Marengoni, A., Bernabei, R., & Onder, G. (2018). Hypertension and frailty: a systematic review and meta-analysis. BMJ open, 8(12), e024406.
- García-de-Alba-García, J. E., Salcedo-Rocha, A. L., & De-la-Rosa-Hernández, S. (2020). The status of frailty in poor older adults with type 2 diabetes mellitus or hypertension: the case of Mexico. International Journal of Diabetes in Developing Countries, 40, 303–309.
- Gi-June Min, G. J., Cho, B.-S., Kwag, D., Lee, J. H., Bang, S.-H., Park, S.-S., . . . Eom, K.-S. (2023). Changes in Physical Function during Intensive Chemotherapy in Older Adults with AML Affect Post-Transplant Survival. Paper presented at the 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR.
- Petrov, D., Timilshina, N., Papadopoulos, E., & Alibhai, S. M. (2022): Performance of the frailty index in predicting complete remission, intensive care unit admission, and overall mortality in older and younger patients with acute myeloid leukemia receiving intensive chemotherapy. Leukemia & Lymphoma, 63(9), 2189–2196.
- Lee, M. H., La, J., Brophy, M., Do, N. V., Driver, J. A., Tuck, D. P., ... & Dumontier, C. (2022): Baseline Correlates of Frailty and Its Association with Survival in US Veterans with Newly Diagnosed and Treated Acute Myeloid Leukemia. Blood, 140(Supplement 1), 8117–8118.
- Umit, E. G., Baysal, M., & Demir, A. M. (2018): Frailty in patients with acute myeloid leukaemia, conceptual misapprehension of chronological age. European Journal of Cancer Care, 27(2), e12810.
- Budziszewska, B. K., Pluta, A., Sulek, K., Wierzbowska, A., Robak, T., Giebel, S., & Lech-Maranda, E. (2015): Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study. Leukemia & Lymphoma, 56(8), 2331–2338.
- Klepin, H. D., Geiger, A. M., Tooze, J. A., Kritchevsky, S. B., Williamson, J. D., Pardee, T. S., & Powell, B. L. (2013): Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood, The Journal of the American Society of Hematology, 121(21), 4287–4294.
- Volpato, S., Cavalieri, M., Sioulis, F., Guerra, G., Maraldi, C., Zuliani, G., & Guralnik, J. M. (2011): Predictive value of the Short Physical Performance Battery following hospitalization in older patients. Journals of gerontology series a: biomedical sciences and medical sciences, 66(1), 89–96.